Detalles de la búsqueda
1.
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
Br J Haematol;
204(5): 1762-1770, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38500476
2.
Clinicopathologic analysis of a large series of microinvasive breast cancers.
Breast J;
24(4): 574-579, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29476574
3.
Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
J Genet Couns;
26(4): 697-715, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27826805
4.
Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
J Oral Maxillofac Surg;
74(4): 738-46, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26501428
5.
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial.
Nat Med;
28(5): 939-945, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422531
6.
HER2 Testing Characteristics Can Predict Residual Cancer Burden following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.
Int J Breast Cancer;
2021: 6684629, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34123431
7.
HER2 Testing: Insights From Pathologists' Perspective on Technically Challenging HER2 FISH Cases.
Appl Immunohistochem Mol Morphol;
29(9): 635-642, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34282066
8.
Effects of Germline Pathogenic Variants, Cancer Subtypes, Tumor-related Characteristics, and Pregnancy-associated Diagnosis on Outcomes.
Clin Breast Cancer;
21(1): 47-56, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32739136
9.
Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study.
Clin Cancer Res;
27(11): 3061-3068, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33727258
10.
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Clin Cancer Res;
26(23): 6132-6140, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32998961
11.
Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance.
NPJ Precis Oncol;
4: 15, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32596507
12.
Utility of Oncotype DX Risk Assessment in Patients With Invasive Lobular Carcinoma.
Clin Breast Cancer;
16(1): 45-50, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385397
13.
Surgical Outcomes of Lobular Neoplasia Diagnosed in Core Biopsy: Prospective Study of 316 Cases.
Clin Breast Cancer;
16(6): 507-513, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27425222
14.
Cancer rehabilitation: outcome evaluation of a strengthening and conditioning program.
Cancer Nurs;
37(3): 162-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23519042
15.
Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw.
J Periodontol;
85(2): 226-33, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23786404
16.
Effectiveness of treatment summaries in increasing breast and colorectal cancer survivors' knowledge about their diagnosis and treatment.
J Cancer Surviv;
7(2): 211-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23417167
17.
Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
Oncol Nurs Forum;
40(6): 549-57, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24161633
18.
Breast and colorectal cancer survivors' knowledge about their diagnosis and treatment.
J Cancer Surviv;
6(1): 20-32, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21735277
Resultados
1 -
18
de 18
1
Próxima >
>>